![]() Item Type:įunding information: Cancer Research UK, Grant/Award Number: C48006/A20863 Chief Scientist Office, Grant/Award Number: HIPS/16/1 Health and Social Care Northern Ireland, Grant/Award Number: COM/5352/17 Lullaby Trust, Grant/Award Number: 272 Northern IrelandĬhest Heart and Stroke, Grant/Award Number: 2019_09 Public Health Agency NI, Grant/Award Number: No reference available Scottish Cot Death Trust. In the United Kingdom, offering up to £400 financial incentives, in addition to usual care, to support pregnant women to stop smoking appears to be highly cost-effective over a lifetime for mother and infants. These findings indicate that, over a lifetime, financial incentives are cost saving and improve health outcomes. The long-term analysis combined costs and outcomes for mother and infants results showed a cost saving of £37 (95% confidence interval = £35 to £106) and increase in QALYs of 0.171 (95%CI = 0.124 to 0.229). Results of sensitivity analyses confirmed these results. The short-term incremental cost per quitter was £4,400 and cost per QALY was £150,000. Costs are presented in 2020 GBP sterling (£).ĭata for the lifetime analysis came from the trial and were combined with data from published literature embedded in the model, reporting incremental cost per quitter and QALY. ![]() ![]() The outcome measure was biochemically verified quit rate for the CEA and quality adjusted life-years (QALY) for CUA. The same population was used for the lifetime analysis, plus their infants.Ĭosts included financial incentive vouchers and postage, cessation support and nicotine replacement therapy and neonatal stays. In the short-term analysis CPIT III participants were assessed: women 16 years or older, self-reporting as smokers, less than 24 weeks pregnant and English speaking (n=944). Seven maternity smoking cessation sites in Scotland, England and Northern Ireland in the United Kingdom. Long-term analyses were conducted from the same perspective, using an existing Markov model over a lifetime horizon. To evaluate whether adding financial incentives to usual care is cost-effective in encouraging pregnant women to quit tobacco smoking, compared with usual care alone.Ĭost-effectiveness analysis (CEA) and cost-utility analysis (CUA) from a healthcare provider’s perspective, embedded in the Smoking Cessation in Pregnancy Incentives Trial (CPIT III).
0 Comments
Leave a Reply. |